Intellia Therapeutics (NTLA) News Today $11.46 +0.09 (+0.79%) Closing price 08/7/2025 04:00 PM EasternExtended Trading$11.54 +0.08 (+0.74%) As of 08/7/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NTLA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Intellia Therapeutics, Inc. (NTLA) Q2 2025 Earnings Call TranscriptAugust 7 at 9:08 PM | seekingalpha.comIntellia (NTLA) Q2 Revenue Jumps 106%August 7 at 12:08 PM | fool.comIntellia Therapeutics Announces Second Quarter 2025 Financial Results and Highlights Recent Company ProgressAugust 7 at 10:04 AM | finance.yahoo.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Bought by XTX Topco LtdAugust 7 at 3:38 AM | marketbeat.comIntellia Therapeutics Sees IBD RS Rating Rise To 76August 6 at 7:01 PM | msn.comIQ EQ FUND MANAGEMENT IRELAND Ltd Grows Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)August 6 at 5:27 AM | marketbeat.comUniversal Beteiligungs und Servicegesellschaft mbH Acquires New Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)August 4, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Purchased by Privium Fund Management B.V.August 3, 2025 | marketbeat.comIntellia Therapeutics (NTLA) to Release Quarterly Earnings on ThursdayAugust 2, 2025 | marketbeat.comIntellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)August 1, 2025 | globenewswire.comINTELLIA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Intellia Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmJuly 31, 2025 | globenewswire.comIntellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company UpdatesJuly 31, 2025 | finance.yahoo.comIntellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2025 Earnings and Company UpdatesJuly 31, 2025 | globenewswire.comGSA Capital Partners LLP Raises Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)July 30, 2025 | marketbeat.comStocks To Watch: Intellia Therapeutics Sees Relative Strength Rating Rise To 80July 28, 2025 | msn.comARK Investment Management LLC Has $92.51 Million Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA)July 27, 2025 | marketbeat.comNikko Asset Management Americas Inc. Lowers Stock Holdings in Intellia Therapeutics, Inc. (NASDAQ:NTLA)July 27, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) EVP Sells $104,617.24 in StockJuly 26, 2025 | marketbeat.comIntellia Therapeutics (NASDAQ:NTLA) Trading 6.9% Higher - Time to Buy?July 26, 2025 | marketbeat.comIntellia Therapeutics (NASDAQ:NTLA) Shares Down 7.6% - What's Next?July 25, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Receives Average Rating of "Moderate Buy" from AnalystsJuly 24, 2025 | marketbeat.comResearch Analysts Offer Predictions for NTLA Q3 EarningsJuly 21, 2025 | marketbeat.com40,946 Shares in Intellia Therapeutics, Inc. (NASDAQ:NTLA) Purchased by Creekmur Asset Management LLCJuly 19, 2025 | marketbeat.comWith Intellia Therapeutics, Human Patience Beat Hot-Take Trading: Still At 'Buy'July 18, 2025 | seekingalpha.comIntellia Therapeutics (NASDAQ:NTLA) Stock Price Up 5.7% - Here's What HappenedJuly 16, 2025 | marketbeat.comGoldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook (NTLA)Goldman Sachs raised its year-end S&P 500 forecast and identified three stocks that are poised to outperform in the second half of 2025: KSS, NTLA, and GOGO.July 15, 2025 | marketbeat.comNTLA - Intellia Therapeutics Inc Trailing Returns - MorningstarJuly 12, 2025 | morningstar.comMMove Over, Magnificent 7: The Frontier 7 Will Redefine Our FutureJuly 10, 2025 | 247wallst.comIntellia Therapeutics (NASDAQ:NTLA) Stock Price Up 6.1% - Should You Buy?July 8, 2025 | marketbeat.comIntellia Therapeutics Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)July 7, 2025 | globenewswire.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) EVP Eliana Clark Sells 1,022 SharesJuly 4, 2025 | insidertrades.comIntellia Therapeutics Inc. Advanced Charts | NTLA | Barron'sJuly 4, 2025 | barrons.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Shares Sold by Sumitomo Mitsui Trust Group Inc.July 4, 2025 | marketbeat.comCitizens JMP Maintains Neutral Stance on Intellia Despite Positive Lonvo-z DataJuly 3, 2025 | msn.comInsider Selling: Intellia Therapeutics, Inc. (NASDAQ:NTLA) EVP Sells $10,036.04 in StockJuly 3, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) CAO Michael P. Dube Sells 2,503 SharesJuly 3, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Director Sells $14,278.81 in StockJuly 2, 2025 | marketbeat.comIntellia Therapeutics (NASDAQ:NTLA) Stock Price Up 6.8% - Here's WhyJuly 2, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NASDAQ:NTLA) Given Average Recommendation of "Moderate Buy" by BrokeragesJune 29, 2025 | marketbeat.comCRISPR Therapeutics vs. Intellia: Which Gene Editing Stock Holds More Potential? - NasdaqJune 27, 2025 | nasdaq.comNTLA - Intellia Therapeutics Inc Chart - MorningstarJune 26, 2025 | morningstar.comMIntellia Therapeutics, Inc. (NTLA) - Yahoo FinanceJune 24, 2025 | finance.yahoo.comNTLA Intellia Therapeutics, Inc. - Seeking AlphaJune 24, 2025 | seekingalpha.comWill Intellia Therapeutics (NASDAQ:NTLA) Spend Its Cash Wisely?June 21, 2025 | finance.yahoo.comIntellia Therapeutics (NASDAQ:NTLA) Shares Down 6.4% - What's Next?June 20, 2025 | marketbeat.comIntellia Therapeutics, Inc. (NTLA) Backed by H.C. Wainwright for 237% Upside PotentialJune 19, 2025 | finance.yahoo.comWedbush Reaffirms Their Hold Rating on Intellia Therapeutics (NTLA)June 18, 2025 | theglobeandmail.comIntellia Therapeutics, Inc. (NTLA) Backed by H.C. Wainwright for 237% Upside PotentialJune 17, 2025 | msn.comIntellia Therapeutics (NASDAQ:NTLA) Shares Gap Up - Here's WhyJune 17, 2025 | marketbeat.comIntellia Therapeutics (NASDAQ:NTLA) Receives Neutral Rating from WedbushJune 16, 2025 | marketbeat.com Get Intellia Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NTLA and its competitors with MarketBeat's FREE daily newsletter. Email Address NTLA Media Mentions By Week NTLA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NTLA News Sentiment▼0.760.39▲Average Medical News Sentiment NTLA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NTLA Articles This Week▼1112▲NTLA Articles Average Week Get Intellia Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NTLA and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Beam Therapeutics News CRISPR Therapeutics News Editas Medicine News Lantheus News ADMA Biologics News Merus News Abivax News TG Therapeutics News Telix Pharmaceuticals News Avidity Biosciences News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NTLA) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmazon’s big Bitcoin embarrassmentBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredAltucher: Trump’s Great Gain is startingNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredCritical AI announcement set to ignite AI 2.0 A new 100% tariff on imported chips just rattled the tech sector—sending some stocks soaring and others tumbli...Timothy Sykes | SponsoredTrump’s new nightmareAccording to Porter Stansberry and Jeff Brown, a government-led financial mobilization is already reshaping Am...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Intellia Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Intellia Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
